GL1X · GenesisL1 explorer

MolNFT v1 · #14694 · protein

Design of non-covalent inhibitors of human cathepsin L. from the 96- residue proregion to optimized tripeptides

1MHW: “Design of non-covalent inhibitors of human cathepsin L. from the 96- residue proregion to optimized…”. X-ray diffraction, 2 ligands (BP4, PEA), 1 pocket (best druggability 0.59). MolNFT v1 #14694 on GenesisL1: 3D structure, binding…

PDB
1MHW
Type
protein
Length
440 residues
Chains
8
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin L; 4-biphenylacetyl-cys-(D)ARG-tyr-N-(2-phenylethyl) amide
EC
3.4.22.15
UniProt
P07711
Ligands
BP4, PEA
Pockets
1 · best druggability 0.59

Structure

x-ray diffraction · 4 distinct chains · 29% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BCathepsin L (EC 3.4.22.15)protein17434% helix, 17% strandP07711
C, DCathepsin L (EC 3.4.22.15)protein417% helix, 39% strandP07711
E, F4-biphenylacetyl-cys-(D)ARG-tyr-N-(2-phenylethyl) amideprotein20% helix, 0% strand—
G, H4-biphenylacetyl-cys-(D)ARG-tyr-N-(2-phenylethyl) amideprotein30% helix, 0% strand—

Ligands and binding sites

  • BP4 · biphenyl-4-ylacetic acid · ligand · 4 copies · chains A, B, D, E, C, F, G, H
  • PEA · 2-phenylethylamine · ligand · 2 copies · chains A, G, B, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13810.590.7633BP4

Interfaces

17 interfaces between chains.

  • B–D · 2523 Ų buried · 52 hydrogen bonds · protein-protein
  • A–C · 2416 Ų buried · 47 hydrogen bonds · protein-protein
  • B–H · 359 Ų buried · 5 hydrogen bonds · protein-protein
  • A–G · 357 Ų buried · 6 hydrogen bonds · protein-protein
  • A–B · 265 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 6 covalent, 4 d-amino, 2 modified (disulfide, covalent ligand, D-amino acid, oxidation).

Compared structures

  • 1MHW · Design of non-covalent inhibitors of human cathepsin L. From the 96-residue proregion to… · the same entry in another collection · chain H against H, TM-score 1.00
  • P07711 · AlphaFold monomer V2.0 prediction for procathepsin L (P07711) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.